We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fission and Fusion Among the Mitochondria

By Biotechdaily staff writers
Posted on 27 Oct 2004
Two recently published studies describe advances in understanding how mitochondria, double-membrane bound intracellular organelles, divide and reform during the process of cell division.

Investigators at Johns Hopkins University (Baltimore, MD, USA), the California Institute of Technology (Palo Alto, USA), and the University of California, Davis (USA) used advanced optical and electronic microscope techniques to study mitochondria that had been isolated from their host cells.

They found that mitochondrial fission and subsequent fusion required mitofusin, an integral mitochondrial membrane protein. More...
A seven amino acid repeat unit formed a coiled structure that spanned the membrane and allowed binding on either side. Mitochondrial outer and inner membrane fusion events were separable and mechanistically distinct, but both required energy supplied by guanosine 5'-triphosphate hydrolysis. These findings were reported in the August 6 and September 17, 2004, issues of Science.

"We observed two distinct stages, with the first involving outer membrane fusion yielding an intermediate structure of two conjoined mitochondria, followed by the subsequent fusion of the inner membranes giving rise to a single mitochondrion,” explained contributing author Dr. J. Michael McCaffery, director of the integrated imaging center at Johns Hopkins University. "Understanding the discrete molecular events that underlie dynamic mitochondrial behavior has the potential to reveal keen insights into the basic and essential cell-mitochondria relationship, leading to increased understanding of the aging process; and potential treatments and perhaps cures of those age-related scourges of Parkinson's and Alzheimer's.”

New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers identified SARS-CoV-2 protein fragments within extracellular vesicles in the blood of long COVID patients (Photo courtesy of Shutterstock)

Blood Biomarker Test Could Confirm Long COVID Diagnosis

Long COVID remains a diagnostic challenge, with clinicians currently relying on a collection of symptoms that appear 12 weeks or more after SARS-CoV-2 infection. No blood tests or biomarkers currently... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Insights into sarcomatoid renal cell carcinoma point to broader use of common immunotherapies (Photo courtesy of Salgia NJ et al., Cancer Cell, 2025)

Novel Gene Signature Predicts Immunotherapy Response in Advanced Kidney Cancers

Sarcomatoid renal cell carcinoma (sRCC) is a rare, aggressive form of kidney cancer comprising about 5% of cases and is typically diagnosed at late stages. Resistant to most therapies, it has shown unusually... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.